Skip to main content

Table 3 Radiological characteristics of the ‘haematoma expansion analysis cohort’

From: Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulation

 

DOAC (N = 356)

VKA (N = 155)

Non-OAC (N = 74)

p values

Variable

N

Value

N

Value

N

Value

DOAC vs. non-OAC

VKA vs. non-OAC

Baseline haematoma volume, mL, median (IQR)

343

9 (3–25)

153

9 (4–23)

72

9 (3–28)

0.954

0.694

Ventricular extension, n (%)

356

140 (39.3)

155

67 (43.2)

74

24 (32.4)

0.267

0.119

Substantial haematoma expansion, n (%)

356

142 (39.9)

155

47 (30.3)

74

22 (29.7)

#

#

Haematoma expansion, absolute (mL), median (IQR)

356

0.6 (0.15–3.5)

155

0.5 (-0.5–2.6)

74

0.6 (-0.3–3.1)

0.583

0.812

De novo ventricular extension, n (%)

216

43 (19.9)

88

9 (10.2)

50

7 (14.0)

0.335

0.506

  1. # no p value given as non-inferiority of DOAC intake vs no anticoagulant treatment was tested, VKA intake vs no anticoagulant treatment respectively